Purchase Order 75N92019P00406
Award Date
9/16/19
Potential Completion Date
3/14/20
Potential Value
$199K
Funding Federal Agency
National Institute of Biomedical Imaging and Bioenginering
Contracting Federal Agency
National Heart Lung and Blood Institute
Awardee
STA Pharmaceutical US LLC
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services, National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering awarded a firm fixed price purchase order to C S Bio Co., a Minority Owned Business, For Profit Organization, Subcontinent Asian (Asian-Indian) American Owned, Subchapter S Corporation. The award is for 10 grams of GMP grade DOTA-EB-TATE with vialing, with a potential value of $245,600.00 and a completion date of December 11, 2018. The award was made in response...
This is a firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to IBA GMBH, a biotechnology company that develops research tools for protein and cell isolation. The contract is for the supply of 5 units of STREP-TACTIN SUPERFLOW 50% SUSPENSION HIGH CAPACITY, catalog number 2-1208-025, at a total ceiling value of $6,424.75. The contract does not have a set-aside designation, and...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $63,800.00 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company, to perform "Small Molecule Target Deconvolution via Cellular Thermal Shift Assay (CETSA)." This requirement was originally posted as a Sources Sought notice, seeking information on qualified sources to perform CETSA experiments, including sample...
This is a $99,715.40 firm fixed-price purchase order awarded to Cisbio US, Inc., a foreign-owned for-profit company, by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The contract is for the provision of assay kits, cell lines, and collagen reagents to support research activities. This award was not set aside and is the latest in a series of similar purchase orders awarded to Cisbio US, Inc. to provide biomarker...
This federal contract award, with an ID of HHSN271201500432P, was issued by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), to Cisbio US, Inc., a foreign-owned for-profit company. The $128,330.00 firm-fixed-price purchase order contract was set aside for a small business. It was awarded on July 21, 2015, with an ultimate completion date of August 21, 2015. Based on Cisbio US, Inc.'s past federal contract experience, the contract...
This federal contract award, HHSN271201500631P, was made by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS), to Cisbio US, Inc., a foreign-owned for-profit company. The $84,700 firm-fixed-price purchase order contract is for the provision of assay kits and reagents, including those used to detect biomarkers related to disease research, as well as cell lines and collagen reagents. The contract has a total small business...
This federal contract award is for the provision of custom reagents for a Homogeneous Time-Resolved Fluorescence (HTRF) assay, with a ceiling value of $18,700.00. The contract was awarded to Cisbio US, Inc., a foreign-owned for-profit organization that provides assay kits and reagents to the U.S. federal government, particularly the Department of Health and Human Services (HHS) and its agencies such as the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Proteros Biostructures GMBH, a foreign-owned for-profit organization and manufacturer of goods. The contract is for $38,035.00 and is for x-ray structure analyses of eEF1A2 and c-Abl in complex with ligands. The contract was awarded on September 3, 2015 and has a completion date of September 7, 2016....
This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED for the acquisition of 15 grams of PT-2977 (CAS: 1672668-24-4) with a chemical purity exceeding 95% and enantiopurity exceeding 95%. The contract has a ceiling value of $24,800.00 and a completion date of July 8, 2020. This award is not associated with any set-aside program. Wuxi...
This firm-fixed-price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The $11,593.80 award is for the delivery of HU PB MONOCYTES, CRYO, 4X10E7 (2 VIALS), with a completion date of July 15, 2024. The contract has no set-aside designation. Stemcell Technologies Inc. is a supplier of...